Results 71 to 80 of about 5,257 (166)

Tolvaptan for the Treatment of Refractory Ascites

open access: yesInternal Medicine, 2016
Masayuki Kurosaki, Namiki Izumi
openaire   +3 more sources

The management of polycystic liver disease by tolvaptan

open access: yesClinical and Molecular Hepatology, 2020
Masaki Kitajima   +2 more
openaire   +3 more sources

Potential amelioration of liver function by low-dose tolvaptan in heart failure patients. [PDF]

open access: yesToxicol Rep
Mino Y   +8 more
europepmc   +1 more source

MP052THE USEFULNESS OF TOLVAPTAN IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE WITH CHRONIC KIDNEY DISEASE STAGE G3 TO G4 [PDF]

open access: bronze, 2016
Kazunori Yamada   +11 more
openalex   +1 more source

Effectiveness of Tolvaptan for Autosomal Dominant Polycystic Kidney Disease in US Clinical Practice With Comparison to Historical Control Data. [PDF]

open access: yesKidney Med
Perrone RD   +9 more
europepmc   +1 more source

Effects of tolvaptan on urine output in hospitalized heart failure patients with hypoalbuminemia or proteinuria [PDF]

open access: hybrid, 2017
Koji Takagi   +13 more
openalex   +1 more source

A secondary analysis of concurrent use of metformin and tolvaptan in ADPKD tolvaptan trials

open access: yesJournal of Nephrology
I. Kitty Stanley   +6 more
openaire   +2 more sources

Efficacy And Safety of Coadministration of Tolvaptan And Carperitide for Acute Decompensated Heart Failure Patients

open access: hybrid, 2015
Hideyuki Muramatsu   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy